Buy Certified Pharmaceutical Impurity Standards for Research and Regulatory Compliance

Buy Pharmaceutical Impurity Standards | API Impurities & Reference Materials – SpectrasynthIntroductionIn today’s highly regulated pharmaceutical landscape, the accuracy and reliability of impurity standards are vital for ensuring product quality and patient safety. At Spectrasynth, we manufacture and supply a wide range of certified impurity reference standards and custom-synthesized impurities to support pharmaceutical research, stability testing, and regulatory compliance.Our impurity standards are developed under strict quality control, characterized by HPLC, LC-MS, NMR, and IR, and accompanied by complete Certificates of Analysis (CoA) to guarantee authenticity and consistency.Wide Range of API Impurities and Reference StandardsSpectrasynth’s impurity catalogue includes key molecules from several therapeutic areas—cardiology, neurology, gastroenterology, oncology, and anti-infectives. Below are some of the most requested standards available for immediate supply: We provide Warfarin Impurity A (CAS 129-06-6) and Warfarin Impurity B (CAS 81-81-2) to support anticoagulant quality control and validation studies. Our Zafirlukast Impurity A (CAS 107753-78-6) and Zafirlukast Impurity B (CAS 107753-79-7) are trusted by respiratory drug manufacturers for precise impurity profiling. For antiviral R&D, we offer Zidovudine Impurity A (CAS 30516-87-1) and Zidovudine Impurity B (CAS 30516-88-2)—both essential for stability and degradation analysis. Sleep-disorder drug testing is supported with Zolpidem Impurity A (CAS 82626-48-0) and Zolpidem Impurity B (CAS 82626-49-1).In the diabetic therapy class, Alogliptin Impurity A (CAS 850649-62-5) and Alogliptin Impurity B (CAS 850649-63-6) are part of our well-characterized gliptin impurity portfolio. We also supply Apixaban Impurity A (CAS 503612-47-3) and Apixaban Impurity B (CAS 503612-48-4)—critical standards for blood-thinner drug validation.Our cardiovascular range includes Betahistine Impurity A (CAS 563-80-4), Betahistine Impurity B (CAS 563-81-5), Celecoxib Impurity A (CAS 169590-42-5), and Celecoxib Impurity B (CAS 169590-43-6), helping ensure consistent product safety. Ciprofloxacin Impurity A (CAS 85721-33-1) and Impurity B (CAS 85721-34-2) support antibiotic development, while Clindamycin Impurity A (CAS 18323-44-9) and Impurity B (CAS 18323-45-0) are used in antibacterial stability studies. Our anticoagulant and antiplatelet category features Dabigatran Impurity A (CAS 211915-14-0), Dabigatran Impurity B (CAS 211915-15-1), along with Apixaban and Warfarin impurities, covering the major oral blood-thinning drugs used globally. For antidepressant and neurological applications, we supply Desvenlafaxine Impurity A (CAS 93413-62-8) and Impurity B (CAS 93413-63-9), as well as Lisinopril Impurity A (CAS 87502-38-3) and B (CAS 87502-39-4) for ACE inhibitor profiling. Our proton pump inhibitor range includes Dexlansoprazole Impurity A (CAS 206593-63-4), Impurity B (CAS 206593-64-5), Esomeprazole Impurity A (CAS 172060-41-4), and Impurity B (CAS 172060-42-5). For modern antiretroviral and oncology research, Dolutegravir Impurity A (CAS 1051373-41-6) and Impurity B (CAS 1051373-42-7), as well as Imatinib Impurity A (CAS 152459-95-5) and Impurity B (CAS 152459-96-6), are available for regulatory testing. We also provide Enalapril Impurity A (CAS 75847-73-3) and B (CAS 75847-74-4), Entacapone Impurity A (CAS 130929-57-6) and B (CAS 130929-58-7), Etoricoxib Impurity A (CAS 202409-33-4) and B (CAS 202409-34-5), and Fingolimod Impurity A (CAS 162359-56-0) and B (CAS 162359-57-1) to cover multiple therapeutic segments. For lipid management, Fluvastatin Impurity A (CAS 93957-55-2) and Impurity B (CAS 93957-56-3) ensure reproducible quality testing. Allergy and antihistamine testing is supported with Loratadine Impurity A (CAS 79794-75-5) and B (CAS 79794-76-6). We also cover Losartan Impurity A (CAS 114798-26-4) and B (CAS 114798-27-5) for hypertension therapy validation, along with Metoprolol Impurity A (CAS 37350-58-6) and B (CAS 37350-59-7). Additional impurities like Naproxen Impurity C (CAS 22204-55-3), Nifedipine Impurity A (CAS 21829-25-4), and Nifedipine Impurity B (CAS 21829-26-5) are available for anti-inflammatory and cardiovascular drugs.Why Choose Spectrasynth for API Impurities1. Global Regulatory Compliance All impurity standards adhere to ICH, FDA, EMA, and CDSCO requirements, making them suitable for worldwide submissions.2. Certified Quality & Documentation Each impurity is accompanied by a Certificate of Analysis (CoA) detailing purity, structure confirmation, and analytical data.3. Custom Synthesis Expertise If a specific impurity or intermediate is unavailable, our team provides custom synthesis and isotope-labeled standards on request.4. Consistency and Reproducibility We ensure every batch meets the same analytical specifications for reproducible research outcomes.5. Fast Global Delivery With an efficient export network, Spectrasynth supplies impurity standards to pharma companies, CROs, and research labs across India, Europe, and the US.Supporting Global Pharmaceutical ResearchOur impurity standards play a critical role in:Method development and validation for QC and R&D labs.Stability and degradation studies across formulations.Impurity profiling for ANDA, DMF, and NDA submissions.Training and reference benchmarking for regulatory audits.With each product designed for precision, purity, and compliance, Spectrasynth continues to be a trusted name among pharmaceutical impurity manufacturers and suppliers in India.ConclusionFrom Warfarin to Zolpidem, Imatinib, and Esomeprazole, Spectrasynth offers a diverse collection of pharmaceutical impurity standards to meet the needs of modern R&D and regulatory testing. Each product represents our commitment to quality, consistency, and global compliance—making us a reliable partner for pharmaceutical innovators worldwide.👉 Contact Spectrasynth today to request your required impurity standards or discuss custom synthesis projects tailored to your research needs.